This study is an evaluation of low dose paclitaxel in the treatment of aids-rela -ted kaposi's sarcoma. Paclitaxel will be given at a dose of 100 mg/m2 every 2 weeks. Patients are evaluated for toxicity & response to therapy. Prior pharmacokinetics studies on blood have been performed. the purpose of the current study is to determine the clearance of the drug in the urine and feces.
Showing the most recent 10 out of 565 publications